1-9 of 9
A Samer Al-Homsi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation

A Samer Al-Homsi, Frank Cirrone, Kelli Cole, Jaime Andres Suarez-Londono, Sharon L. Gardner, Jingmei Hsu, Stephanie Wo, Kelsey Stocker, Benedetto Bruno, Judith Goldberg, Benjamin Levinson, Maher Abdul-Hay
Journal: Blood
Blood (2022) 140 (Supplement 1): 7628–7630.
https://doi.org/10.1182/blood-2022-162634
Published: 2022
Journal Articles

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis

Clinical Trials & Observations
Kira Bona, Ruta Brazauskas, Naya He, Leslie Lehmann, Hisham Abdel-Azim, Ibrahim A Ahmed, A Samer Al-Homsi, Mahmoud Aljurf, Staci D. Arnold, Sherif M Badawy, Minoo Battiwalla, Sara Beattie, Neel S. Bhatt, Jignesh Dalal, Christopher E. Dandoy, Miguel Angel Diaz, Haydar A. Frangoul, César O. Freytes, Siddhartha Ganguly, Biju George, David Gomez-Almaguer, Theresa Hahn, Rammurti T. Kamble, Jennifer M. Knight, C. Fred LeMaistre, Jason Law, Hillard M. Lazarus, Navneet S. Majhail, Richard F. Olsson, Jaime Preussler, Bipin N. Savani, Raquel Schears, Sachiko Seo, Akshay Sharma, Alok Srivastava, Amir Steinberg, David Szwajcer, Baldeep Wirk, Ayami Yoshimi, Nandita Khera, William A. Wood, Shahrukh Hashmi, Christine N. Duncan, Wael Saber
Journal: Blood
Blood (2021) 137 (4): 556–568.
https://doi.org/10.1182/blood.2020006252
Published: 2021
Includes: Supplemental data
Journal Articles

Results from the Phase I Clinical Studies Evaluating Cyad-01, a First-Generation NKG2D CAR T-Cell Product in Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

David A. Sallman, MD, A. Samer Al-Homsi, MD, Marco L. Davila, MD PhD, Tessa Kerre, MD, Ine Moors, MD, Xavier Poire, MD, Violaine Havelange, MD, Philippe Lewalle, MD, Daniel A. Pollyea, Eunice S. Wang, MD, William Blum, MD, Benjamin Demoulin, PhD, Panagiota A. Sotiropoulou, PhD, Erik Alcantar-Orozco, MD, Eytan Breman, Marie-Sophie Dheur, PhD PharmD, Nathalie Braun, Caroline Lonez, PhD, David E Gilham, PhD, Anne Flament, MD, Frédéric F. Lehmann, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-139609
Published: 2020
Journal Articles

Clinical Development of a Non-Gene-Edited Allogeneic Bcma-Targeting CAR T-Cell Product in Relapsed or Refractory Multiple Myeloma

A. Samer Al-Homsi, MD, Sebastien Anguille, MD, Jason Brayer, PhDMD, Dries Deeren, MD PhD, Nathalie Meuleman, PhD MD, Gareth Morgan, MDPhDFRCP, Taiga Nishihori, MD, Panagiota A. Sotiropoulou, PhD, Laure Twyffels, PhD, Jennifer Bolsee, PhD, Nathalie Braun, Caroline Lonez, PhD, David E Gilham, PhD, Anne Flament, MD, Frédéric F. Lehmann, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-139516
Published: 2020
Journal Articles

Interim Results from the Phase I Deplethink Trial Evaluating the Infusion of a NKG2D CAR T-Cell Therapy Post a Non-Myeloablative Conditioning in Relapse or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

A. Samer Al-Homsi, MD, Enkhtsetseg Purev, MD PhD, Philippe Lewalle, Maher Abdul-Hay, MD, Daniel A Pollyea, MD, Adriano Salaroli, MD, Thomas Lequertier, Erik Alcantar-Orozco, MD, Fabian Borghese, Caroline Lonez, PhD, Nathalie Braun, Florence Renard, Anne Flament, MD, Ine Moors, MD, Tessa Kerre
Journal: Blood
Blood (2019) 134 (Supplement_1): 3844.
https://doi.org/10.1182/blood-2019-128267
Published: 2019
Journal Articles

Post-Transplant Cyclophosphamide Overcomes Graft-Versus-Host Disease Aggravation Induced By Extended Administration of Proteasome Inhibitors

A. Samer Al-Homsi, MD, Austin Goodyke, Kelli Cole, MSN, Marlee Muilenburg, BSN, Michael McLane, Sarah Abdel-Mageed, Muneer H. Abidi, MD, Stephanie F. Williams, MD
Journal: Blood
Blood (2016) 128 (22): 4543.
https://doi.org/10.1182/blood.V128.22.4543.4543
Published: 2016
Journal Articles

Bendamustine, Carfilzomib, and Melphalan (BCM) Conditioning Prior to Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Feasibility Study

A. Samer Al-Homsi, MD, Marlee Muilenburg, BSN, Kelli Cole, MSN, Muneer H. Abidi, MD, Stephanie F. Williams, MD
Journal: Blood
Blood (2016) 128 (22): 4635.
https://doi.org/10.1182/blood.V128.22.4635.4635
Published: 2016
Journal Articles

Ixazomib Impairs Dendritic Cell Function and T Cell Proliferation and Affects the Development of GvHD in a Schedule-Dependent Fashion

Yuxin Feng, PhD, Austin Goodyke, Marlee Muilenberg, BSN, RN, Kelli Cole, MSN, RN, Kathleen Cannady, DVM, Anding Shen, PhD, A. Samer Al-Homsi, MD
Journal: Blood
Blood (2015) 126 (23): 1881.
https://doi.org/10.1182/blood.V126.23.1881.1881
Published: 2015
Journal Articles

Post-Transplant Cyclophosphamide and Bortezomib Combination for Prevention of GvHD after Allogeneic Blood and Marrow Transplantation Is Feasible and Produces Favorable Outcomes

A. Samer Al-Homsi, MD, Tara S Roy, NP, Kelli Cole, RN, MSN, Marlee Bogema, RN, BSN, Stephanie F Williams, MD, Ulrich A. Duffner, MD, Aly Mageed, MD
Journal: Blood
Blood (2014) 124 (21): 3920.
https://doi.org/10.1182/blood.V124.21.3920.3920
Published: 2014